Series B - New Haven Pharmaceuticals - Oct 23, 2014 Funding Round Profile - Cointime

Bitcoin $97,743.93 +0.44%
Ethereum $3,489.75 +4.82%
BNB $665.75 +2.95%
Optimism $2.26 +8.48%
Arbitrum $0.92 +10.95%
Solana $250.79 +2.43%
Polygon $0.59 +10.00%
Cosmos $8.64 +0.67%
Avalanche $44.87 +13.98%

Bitcoin $97,743.93 +0.44%
Ethereum $3,489.75 +4.82%
BNB $665.75 +2.95%
Optimism $2.26 +8.48%
Arbitrum $0.92 +10.95%
Solana $250.79 +2.43%
Polygon $0.59 +10.00%
Cosmos $8.64 +0.67%
Avalanche $44.87 +13.98%

New Haven Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 11.78M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail